{"ticker": {"uuid": "cedc6b7c-a948-476d-8314-10c2a77496d8", "symbol": "IDIA", "name": "Idorsia Ltd", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Idorsia (SWX:IDIA) Valuation After CHF 250 Million Term Loan Reshapes Debt And Liquidity", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Catches Its Breath, Trigano Stalls", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOZXA0anlFOTBXeTZMR3dVdTBWWWJGTEdoYndBWkZfbEFHeGxWbWlXcWhxOHNFZS1PV0N4RlByV01ncGNLN0FFdHZHRWNrLTZCc1JxRU9FV3BVYzhJSlpQNVVLaEdzbFRscGlvZUxJMnJkX1NSZkhkajFCdVpMRHFJN1JwRTdjUUNYV1AxaTItRHlDSC1sZUZhNGN3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd Strengthens Financial Position with Up to CHF 250 Million Loan from Pharmakon Advisors, LP", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNUkxXckRQUEt0UEdScXQzVnA3S0J1bFlJX1RCVVB4WlZmZE03aUxOR0l4T1NMZHRlUFYxNzF2UTh0SV9aeTJJdkVxTlpwa3JNdjZTUXdiOGlWaWZLUUZkaS1DRVV4eW5iSkhsMUVCTlpHV1FYbjZoc25rQXNsQXUxbDl1VGU1VktFd0o2dzBPLVg4LUhwWEZYeVdqTHIxSFJaRk9fOXFTWDZGRnNFUW1wR1pSRnVFZl9VZDEyQVBkNXQ2aDA3dTZ4V3NFSVI2ZGo1TGhwUUlmMjlzUVBSaUZDeFJRVDd3Zw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Idorsia (SWX:IDIA) After Its Sharp 1-Year Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNalZTR0lGNEQxLTJXYWFUZXR0VW5zcEtuUkRLVlVaZ3VtQzhtVnJKUjhpaHZVeC10UW9zUHl3MjdtSWJzaHFEUHZGSVlVU094cklRbXh2YzNMaW9BS2JvTng4ZnBSb2NfdEs0WVU3VnpxNnMyZ08zN09YaG9mM0tpSnNyNHk4aU5uSTgybXczRFRVZDdvQkIwTFNn?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Idorsia (SWX:IDIA) Story Is Shifting As Price Targets And Risks Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNX1FCQk0tdnZENVE2NXZETDhyWDMxN0VETjl6eGhSbzdxcEU2MTNOOUpfY2xLd2hleGdHRTdoUTlnU2F1dkhjTjRlR3ljYVE2QUtPUktFWC1PWnliMkkyN3hQSnZKSFhFajdYTEtGSk45VEF0dk90RlkyUmlmLXQ5QmlBbl80cU0xVl83MlN0R29SM0JlVUVJWmQycWo?oc=5", "source_name": "Market source", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The Idorsia (SWX:IDIA) Narrative Is Resetting As Price Targets And Risks Evolve", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWkRkT2Ffend4dllwaVRTVGpVc09fSHQxS3Jjd3A3cUlZYXlLSEhPajZpY2dWZExNZ0JPYmxSQUFCN1dfbUloN1lXN25xMHpvUGJubGh4c2h6SC12OEp2UGFqOUtjY0xRSTU3TGNuaVVwNW1FRDNYU1ZkdnFhVWhqeFRkZjlfd1cwWjN1YlN2NzFDczE2Snd5Q0VMcw?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Swiss pharma firm Idorsia CEO resigns after less than a year", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNa3JBMWlZdXEtZTBvb1c0YmJjTGloNm14X1pBSWZuZVhLQVZlMkhocE9wN25OU1dYZkFDbTh5NUtZVWhEV2dtNGE0aFlCaXA1dkdGUGw5Z19ISF9FQmlYaERkbGpmUlVUZGp6a0RHbXlRT2lWSXctUjNtb3Zpb2JadnY2Vms2ak9ZZE9EUk05Z2NHWG9zWlIxOERIQTBaSFFyVF9rZjBHdzd1Y08yYVVJdjZB?oc=5", "source_name": "SWI swissinfo.ch", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Idorsia\u2019s Latin America QUVIVIQ Deal and Lucerastat Data Change The Bull Case For Idorsia (SWX:IDIA)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Latin America QUVIVIQ Deal Could Be A Game Changer For Idorsia (SWX:IDIA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPcGJaVlRyRXNCalNDdXlMSzZRNVBBdXlUTWk1U0szZEZfODh4MkxUVy1vbHlzRUlJQnVuMkQwSmNHR1F4Wm9YZVlSSVM1aGZ1SlZNVFZ0LXlxYVZGS2g2b1RwdjE2OWZhWHI3bjFzSXRiZjJfTFJhNGt3cEZCSFJldDRKVEY?oc=5", "source_name": "Market source", "published_at": "2026-02-01T08:00:00+00:00", "published_display": "01 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia\u2019s daridorexant in women during menopausal transition age with insomnia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQR2h0eWotb1ZxMm92VVJrYmtlWUE2b2ZMODJhaUJOZXlNS21CTUlsbkM4eTdNWXQtV3FvVHdFUFZJQ3oxNG5BZ21HVWtKWnhaczdMSC1PTEd0S0VaV1ZpYVVRdmlFc2tuODRqd3czb1Ztb2RURnYtQXlaRDUtYWUzZGtYeXBpYW1tUUZEM0ZRM0VMVjdaeUswQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd (VTX:IDIA) Surges 28% Yet Its Low P/S Is No Reason For Excitement", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Global expansion of Idorsia\u2019s QUVIVIQ continues as Simcere launches in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOMlNBWUtqMV9MbDV6MlhMbjU3a3hudUdUcmF0SF9DaXczMzBCWkNUUklEMXIzeXhMNXlLdkhmN1NCUVczS0JKdjBhdVI2OVIzZXdWNlFEdHh6RHhrUm5mRTh0RGxGbVpxRC1SLTQ2Q1ZtUkowUFZRZVBaUEJRdkFBcUUxSlZVMFM5SE5UN0E2dENlNXJ2dXc?oc=5", "source_name": "Market source", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia H1 2025 presentation: QUVIVIQ sales surge, profitability horizon in sight", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxObXdlNUxOek5EOGxMRWhmT1E2aXpBMVhhU2cwV0hUYnZjUnR1M0RCUlpqQkQ1M2RiRXkwcHlZUzJsNGlMREJnNUlPcElFMEFTMG5mZmxOUW9SWnByNXJEeHpqakd4d0hMU3kzclRqM2JWbkhoN0tqOVFxa0JiZkRJT1QxdDRrNTFqa0Y2ZXBOZzZIM3RMblYxZE13ZlNBYjZxU2ZyV291TjlpN2FCZ1YyTVk1MDUzTXFwX21FdkhNQXp3cE9FRktXTEI1NUJuekFZOXc?oc=5", "source_name": "Investing.com", "published_at": "2025-07-30T07:00:00+00:00", "published_display": "30 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia\u2019s Tryvio deal collapses, forcing company to find cash urgently", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOOGhuem02cXlWWVV0LVl0eUJNY3k0aHhEYXh1dzkweU5PLTdmYXRpeEN1YThJOUhMTm96SVF3d3MzR3lLVXN5b3NmRXVSNlU4c0hOWlBTSHlRWVNwcEEwN0JjWWNtVXEyUjBFc1N6TkViLUVxV1VuV2RBZncwSEZuekROY05IWlRicVVqbUtVV0wwdUppVnNnM0JCejFKaXdnc1F6dklhakp4TDRTcVpOaHNCanhvWEU?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-02-26T08:00:00+00:00", "published_display": "26 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J \u2018mistake\u2019? Idorsia\u2019s Tryvio wins FDA nod in hypertension", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQY241cUxZaG85Vk9yc2JFNlhCQnl2MXRxTW5oSkEtdVZNbFI4NFE1YTZxNmo2anM4cTNhQ3g2TS1VZ1VzcEFVOVFycHI0THRlVWZSSDlucGhocTlZejRpbDFHLVJhYmtrVjk0a2ZEX1FUalppUVVESUtfTkhzNENSMVhJLTZBUVhMVFdfaUNXN1gyQnlES2F4cHNUOGxpbDhwVUp3?oc=5", "source_name": "BioWorld News", "published_at": "2024-03-20T07:00:00+00:00", "published_display": "20 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J hands back $230M blood pressure drug to Idorsia with approval in sight", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPaEhDSEVKZmpmaTBYTGYzUXQ2SWc4bXhEcFFYeGdSQjBuaW5YbDhtMnFlOWJ4d3NweXAxZ3RwOXJHaFYwaWlQZm5jaU9GQzFvRlowLXlOY3NVTUZydWk0bmNTMk9ZUndYMnZsZUZVUzRfTkZQSGJhSk01eEtoTzVjZ1FYc3pMbEZVTHpUUlJjS1RMOUh0cEE?oc=5", "source_name": "Fierce Biotech", "published_at": "2023-09-06T07:00:00+00:00", "published_display": "06 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia shares sink on \u2018unexpected\u2019 failure of drug study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQVVZWcktJazVPa1ZpR1RGX2RMUHZPaHV4U1B2QXVZX0R0VDFVNmdTSDFsUktkTUEwcnVVclJOOUhPMmFXUWFzLVQ1ZW5STFMwMkpLQ0FmdC1vOHoxZ0J1RzNIUnNDWHY1MENIeUJqbFJjejdFYzhLTGpNU2VlQk5SdG5wdFhzeEQ0VVE?oc=5", "source_name": "BioPharma Dive", "published_at": "2023-02-06T08:00:00+00:00", "published_display": "06 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia's Fabry med did what executives were expecting\u2014it just didn't relieve the disease's hallmark burning pain", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQMnlkUjZzclV2cHVsdXBuY0pDNmhVVExvX3BDa3dXRkNSR1FsSEdMLTJuQzNWaDdHUW50eFFBcE5nQ0x3blFjSkZVei05Qld2czdvWDE5X0t0c2RWX2FpM2g1Ny1HMGp3aEhMNEJWMFJkb3gxeGFsU25NTVVlU1BCclBQOU9SZDdjWGFpQUdlX3RUX0ZmTmstWExyeElaZEpuck9RMDZDQjNiUDVaaWlhUldWRG92dEx1YkQyZQ?oc=5", "source_name": "Fierce Biotech", "published_at": "2021-10-11T07:00:00+00:00", "published_display": "11 Oct 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1pQjd3djdDRUp3YWNjMkFZbE1CSk5nVDkyYVgxRVotTENybVdnWk9Rdmx4czJobFliUFdlMXQ4eVBDVHJyZ0ZDVUMyZFpCRzQ4N0ZEby0zdw?oc=5", "source_name": "Reuters", "published_at": "2021-06-28T05:34:59+00:00", "published_display": "28 Jun 2021 05:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd: Target Price Consensus and Analysts Recommendations | IDIA | CH0363463438", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5oT2FwR2VfMGxEV2RxRHRZeDJ6aUs5X1h1dnRSNUtKcGhvOThWYzljSTlVa0cxWU40VXI4dGFzcWlYZ0FWaDNJSWdseV9vazdGcFJqOEJEZE9zNTMyRDBzaVUxMnNFdFNvM2piN2w1bXJkQm5CM0xUMVdLVm0wT3c?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T17:33:19+00:00", "published_display": "18 Aug 2020 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia spins out of Johnson & Johnson-Actelion with $1B and multidrug pipeline, sees shares jump 30% on first day of trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRWp5aDRYcGI5NFdQLXd4VjcxMGZPbWYtbWlqTFZsUmF2Rk1WM09xOFJZTk9nZGlRbklCbWpZVjhLZTVYYzF6amxrMTAxZThoWm4tckNEdHhCbldNdzYyTFVsMndFSE5vTEVRRjhQZ1FzSlprZ3A4eGRlaUF1eXNWSXVjemk0U05oQmoyVGhDQk9OOVNYVFFYbUJ4cVVNOGY3cXZvbS1xNHpmN3dVLTlvSFUxLWdWNmwzejZ5UWhtUndudjA?oc=5", "source_name": "Fierce Biotech", "published_at": "2017-06-16T07:00:00+00:00", "published_display": "16 Jun 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Idorsia (SWX:IDIA) Valuation After CHF 250 Million Term Loan Reshapes Debt And Liquidity", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNUGlhaE94LXNuR2IyZkowTl80bHVwaU0yODBkcmJudXhVTU9pMWs0TlhXWFluWElucm1RQVFyLVB6RmdTOXRHYkJidU90WlVzQUpnNWFlNHJ2NU4yNHJDdkJTZzVNU1ZWNm1PcUhvOWFZMXFIc1pRN05lWGtlMUVSd2R1THlFeVZJZWlMYk5qa2pUN2wxZjNGVjJodlEzN2RuMVJYVXdsX2VmdGxHU1l5RU11M045dmZzTWdBRUxOOF9xeUcwSWVQQ2locVJYczJ3YjFLYjVDT0Exa29ia1HSAeMBQVVfeXFMTnpTY1NaRXNZaFRqeC1aVnRBZ0YtWVNwODlpZzhUeVFRXzJabTJ0U1FwYXBjLVd5Y0tZaFJIMXB2NEQ5Vk82SDRUek85T0lXVktjTjI0TE5oSEhrZEs3U0o0WDlwZFRtR2RLTzFHMWc1RDZRUFAtZ09zckxtODIzMHBkdzIweG5OUkdqbWpHYlptUjN4cS1ZRUR2WTV6UnlQeExWWE1KTUg4OWdHd3RXcVh2ZEZtQTZWYkZYSGV3NFZSNUhOOVR1MUZuZnF3akM5MTVBWFhidlUxYTJ0UE14QzZzekU?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Catches Its Breath, Trigano Stalls", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOZXA0anlFOTBXeTZMR3dVdTBWWWJGTEdoYndBWkZfbEFHeGxWbWlXcWhxOHNFZS1PV0N4RlByV01ncGNLN0FFdHZHRWNrLTZCc1JxRU9FV3BVYzhJSlpQNVVLaEdzbFRscGlvZUxJMnJkX1NSZkhkajFCdVpMRHFJN1JwRTdjUUNYV1AxaTItRHlDSC1sZUZhNGN3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd Strengthens Financial Position with Up to CHF 250 Million Loan from Pharmakon Advisors, LP", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNUkxXckRQUEt0UEdScXQzVnA3S0J1bFlJX1RCVVB4WlZmZE03aUxOR0l4T1NMZHRlUFYxNzF2UTh0SV9aeTJJdkVxTlpwa3JNdjZTUXdiOGlWaWZLUUZkaS1DRVV4eW5iSkhsMUVCTlpHV1FYbjZoc25rQXNsQXUxbDl1VGU1VktFd0o2dzBPLVg4LUhwWEZYeVdqTHIxSFJaRk9fOXFTWDZGRnNFUW1wR1pSRnVFZl9VZDEyQVBkNXQ2aDA3dTZ4V3NFSVI2ZGo1TGhwUUlmMjlzUVBSaUZDeFJRVDd3Zw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Idorsia (SWX:IDIA) After Its Sharp 1-Year Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNalZTR0lGNEQxLTJXYWFUZXR0VW5zcEtuUkRLVlVaZ3VtQzhtVnJKUjhpaHZVeC10UW9zUHl3MjdtSWJzaHFEUHZGSVlVU094cklRbXh2YzNMaW9BS2JvTng4ZnBSb2NfdEs0WVU3VnpxNnMyZ08zN09YaG9mM0tpSnNyNHk4aU5uSTgybXczRFRVZDdvQkIwTFNn?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Idorsia (SWX:IDIA) Story Is Shifting As Price Targets And Risks Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNX1FCQk0tdnZENVE2NXZETDhyWDMxN0VETjl6eGhSbzdxcEU2MTNOOUpfY2xLd2hleGdHRTdoUTlnU2F1dkhjTjRlR3ljYVE2QUtPUktFWC1PWnliMkkyN3hQSnZKSFhFajdYTEtGSk45VEF0dk90RlkyUmlmLXQ5QmlBbl80cU0xVl83MlN0R29SM0JlVUVJWmQycWo?oc=5", "source_name": "Market source", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The Idorsia (SWX:IDIA) Narrative Is Resetting As Price Targets And Risks Evolve", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWkRkT2Ffend4dllwaVRTVGpVc09fSHQxS3Jjd3A3cUlZYXlLSEhPajZpY2dWZExNZ0JPYmxSQUFCN1dfbUloN1lXN25xMHpvUGJubGh4c2h6SC12OEp2UGFqOUtjY0xRSTU3TGNuaVVwNW1FRDNYU1ZkdnFhVWhqeFRkZjlfd1cwWjN1YlN2NzFDczE2Snd5Q0VMcw?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Swiss pharma firm Idorsia CEO resigns after less than a year", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNa3JBMWlZdXEtZTBvb1c0YmJjTGloNm14X1pBSWZuZVhLQVZlMkhocE9wN25OU1dYZkFDbTh5NUtZVWhEV2dtNGE0aFlCaXA1dkdGUGw5Z19ISF9FQmlYaERkbGpmUlVUZGp6a0RHbXlRT2lWSXctUjNtb3Zpb2JadnY2Vms2ak9ZZE9EUk05Z2NHWG9zWlIxOERIQTBaSFFyVF9rZjBHdzd1Y08yYVVJdjZB?oc=5", "source_name": "SWI swissinfo.ch", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Idorsia\u2019s Latin America QUVIVIQ Deal and Lucerastat Data Change The Bull Case For Idorsia (SWX:IDIA)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Latin America QUVIVIQ Deal Could Be A Game Changer For Idorsia (SWX:IDIA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPcGJaVlRyRXNCalNDdXlMSzZRNVBBdXlUTWk1U0szZEZfODh4MkxUVy1vbHlzRUlJQnVuMkQwSmNHR1F4Wm9YZVlSSVM1aGZ1SlZNVFZ0LXlxYVZGS2g2b1RwdjE2OWZhWHI3bjFzSXRiZjJfTFJhNGt3cEZCSFJldDRKVEY?oc=5", "source_name": "Market source", "published_at": "2026-02-01T08:00:00+00:00", "published_display": "01 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia\u2019s daridorexant in women during menopausal transition age with insomnia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQR2h0eWotb1ZxMm92VVJrYmtlWUE2b2ZMODJhaUJOZXlNS21CTUlsbkM4eTdNWXQtV3FvVHdFUFZJQ3oxNG5BZ21HVWtKWnhaczdMSC1PTEd0S0VaV1ZpYVVRdmlFc2tuODRqd3czb1Ztb2RURnYtQXlaRDUtYWUzZGtYeXBpYW1tUUZEM0ZRM0VMVjdaeUswQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd (VTX:IDIA) Surges 28% Yet Its Low P/S Is No Reason For Excitement", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Global expansion of Idorsia\u2019s QUVIVIQ continues as Simcere launches in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOMlNBWUtqMV9MbDV6MlhMbjU3a3hudUdUcmF0SF9DaXczMzBCWkNUUklEMXIzeXhMNXlLdkhmN1NCUVczS0JKdjBhdVI2OVIzZXdWNlFEdHh6RHhrUm5mRTh0RGxGbVpxRC1SLTQ2Q1ZtUkowUFZRZVBaUEJRdkFBcUUxSlZVMFM5SE5UN0E2dENlNXJ2dXc?oc=5", "source_name": "Market source", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia H1 2025 presentation: QUVIVIQ sales surge, profitability horizon in sight", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxObXdlNUxOek5EOGxMRWhmT1E2aXpBMVhhU2cwV0hUYnZjUnR1M0RCUlpqQkQ1M2RiRXkwcHlZUzJsNGlMREJnNUlPcElFMEFTMG5mZmxOUW9SWnByNXJEeHpqakd4d0hMU3kzclRqM2JWbkhoN0tqOVFxa0JiZkRJT1QxdDRrNTFqa0Y2ZXBOZzZIM3RMblYxZE13ZlNBYjZxU2ZyV291TjlpN2FCZ1YyTVk1MDUzTXFwX21FdkhNQXp3cE9FRktXTEI1NUJuekFZOXc?oc=5", "source_name": "Investing.com", "published_at": "2025-07-30T07:00:00+00:00", "published_display": "30 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia\u2019s Tryvio deal collapses, forcing company to find cash urgently", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOOGhuem02cXlWWVV0LVl0eUJNY3k0aHhEYXh1dzkweU5PLTdmYXRpeEN1YThJOUhMTm96SVF3d3MzR3lLVXN5b3NmRXVSNlU4c0hOWlBTSHlRWVNwcEEwN0JjWWNtVXEyUjBFc1N6TkViLUVxV1VuV2RBZncwSEZuekROY05IWlRicVVqbUtVV0wwdUppVnNnM0JCejFKaXdnc1F6dklhakp4TDRTcVpOaHNCanhvWEU?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-02-26T08:00:00+00:00", "published_display": "26 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J \u2018mistake\u2019? Idorsia\u2019s Tryvio wins FDA nod in hypertension", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQY241cUxZaG85Vk9yc2JFNlhCQnl2MXRxTW5oSkEtdVZNbFI4NFE1YTZxNmo2anM4cTNhQ3g2TS1VZ1VzcEFVOVFycHI0THRlVWZSSDlucGhocTlZejRpbDFHLVJhYmtrVjk0a2ZEX1FUalppUVVESUtfTkhzNENSMVhJLTZBUVhMVFdfaUNXN1gyQnlES2F4cHNUOGxpbDhwVUp3?oc=5", "source_name": "BioWorld News", "published_at": "2024-03-20T07:00:00+00:00", "published_display": "20 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J hands back $230M blood pressure drug to Idorsia with approval in sight", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPaEhDSEVKZmpmaTBYTGYzUXQ2SWc4bXhEcFFYeGdSQjBuaW5YbDhtMnFlOWJ4d3NweXAxZ3RwOXJHaFYwaWlQZm5jaU9GQzFvRlowLXlOY3NVTUZydWk0bmNTMk9ZUndYMnZsZUZVUzRfTkZQSGJhSk01eEtoTzVjZ1FYc3pMbEZVTHpUUlJjS1RMOUh0cEE?oc=5", "source_name": "Fierce Biotech", "published_at": "2023-09-06T07:00:00+00:00", "published_display": "06 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia shares sink on \u2018unexpected\u2019 failure of drug study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQVVZWcktJazVPa1ZpR1RGX2RMUHZPaHV4U1B2QXVZX0R0VDFVNmdTSDFsUktkTUEwcnVVclJOOUhPMmFXUWFzLVQ1ZW5STFMwMkpLQ0FmdC1vOHoxZ0J1RzNIUnNDWHY1MENIeUJqbFJjejdFYzhLTGpNU2VlQk5SdG5wdFhzeEQ0VVE?oc=5", "source_name": "BioPharma Dive", "published_at": "2023-02-06T08:00:00+00:00", "published_display": "06 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia's Fabry med did what executives were expecting\u2014it just didn't relieve the disease's hallmark burning pain", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQMnlkUjZzclV2cHVsdXBuY0pDNmhVVExvX3BDa3dXRkNSR1FsSEdMLTJuQzNWaDdHUW50eFFBcE5nQ0x3blFjSkZVei05Qld2czdvWDE5X0t0c2RWX2FpM2g1Ny1HMGp3aEhMNEJWMFJkb3gxeGFsU25NTVVlU1BCclBQOU9SZDdjWGFpQUdlX3RUX0ZmTmstWExyeElaZEpuck9RMDZDQjNiUDVaaWlhUldWRG92dEx1YkQyZQ?oc=5", "source_name": "Fierce Biotech", "published_at": "2021-10-11T07:00:00+00:00", "published_display": "11 Oct 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1pQjd3djdDRUp3YWNjMkFZbE1CSk5nVDkyYVgxRVotTENybVdnWk9Rdmx4czJobFliUFdlMXQ4eVBDVHJyZ0ZDVUMyZFpCRzQ4N0ZEby0zdw?oc=5", "source_name": "Reuters", "published_at": "2021-06-28T05:34:59+00:00", "published_display": "28 Jun 2021 05:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia Ltd: Target Price Consensus and Analysts Recommendations | IDIA | CH0363463438", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5oT2FwR2VfMGxEV2RxRHRZeDJ6aUs5X1h1dnRSNUtKcGhvOThWYzljSTlVa0cxWU40VXI4dGFzcWlYZ0FWaDNJSWdseV9vazdGcFJqOEJEZE9zNTMyRDBzaVUxMnNFdFNvM2piN2w1bXJkQm5CM0xUMVdLVm0wT3c?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T17:33:19+00:00", "published_display": "18 Aug 2020 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Idorsia spins out of Johnson & Johnson-Actelion with $1B and multidrug pipeline, sees shares jump 30% on first day of trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRWp5aDRYcGI5NFdQLXd4VjcxMGZPbWYtbWlqTFZsUmF2Rk1WM09xOFJZTk9nZGlRbklCbWpZVjhLZTVYYzF6amxrMTAxZThoWm4tckNEdHhCbldNdzYyTFVsMndFSE5vTEVRRjhQZ1FzSlprZ3A4eGRlaUF1eXNWSXVjemk0U05oQmoyVGhDQk9OOVNYVFFYbUJ4cVVNOGY3cXZvbS1xNHpmN3dVLTlvSFUxLWdWNmwzejZ5UWhtUndudjA?oc=5", "source_name": "Fierce Biotech", "published_at": "2017-06-16T07:00:00+00:00", "published_display": "16 Jun 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 21, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 15, "score": 51, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 8.6, "count": 15}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 5.67, "latest_week": "2026-06-19", "one_week_move": 25.1, "four_week_move": 37.3, "twelve_week_move": 85.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.04279, "market_dynamics_buy_signal": false, "relative_strength": 48.131239, "fair_value_gap": 116.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 57.4941, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+25.1% over one week, +37.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "simplywall.st", "count": 3}, {"label": "marketscreener.com", "count": 3}, {"label": "Fierce Biotech", "count": 3}, {"label": "SWI swissinfo.ch", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Deals and strategy", "count": 3}, {"label": "Balance sheet", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+25.1% over one week, +37.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Idorsia (SWX:IDIA) Valuation After CHF 250 Million Term Loan Reshapes Debt And Liquidity"}], "updated_at": "2026-06-22T17:55:23.242345+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}